Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Cagrilintide for Sale > Factory Supply Weight Loss Peptides Cagrilintide Lyophilized 5mg 10mg 15mg Vials CAS 1415456-99-3
Factory Supply Weight Loss Peptides Cagrilintide Lyophilized 5mg 10mg 15mg Vials CAS 1415456-99-3 buy - large image1
Factory Supply Weight Loss Peptides Cagrilintide Lyophilized 5mg 10mg 15mg Vials CAS 1415456-99-3 buy - image1
Factory Supply Weight Loss Peptides Cagrilintide Lyophilized 5mg 10mg 15mg Vials CAS 1415456-99-3 buy - image2
Factory Supply Weight Loss Peptides Cagrilintide Lyophilized 5mg 10mg 15mg Vials CAS 1415456-99-3 buy - image3
Factory Supply Weight Loss Peptides Cagrilintide Lyophilized 5mg 10mg 15mg Vials CAS 1415456-99-3 buy - image4
Factory Supply Weight Loss Peptides Cagrilintide Lyophilized 5mg 10mg 15mg Vials CAS 1415456-99-3 buy - image5
Factory Supply Weight Loss Peptides Cagrilintide Lyophilized 5mg 10mg 15mg Vials CAS 1415456-99-3 buy - image6

Factory Supply Weight Loss Peptides Cagrilintide Lyophilized 5mg 10mg 15mg Vials CAS 1415456-99-3

TDS 66 Inquiries

Unit Price: Get Latest Price
CAS No.:

1415456-99-3

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shenzhen

Brand:

HORLDEN

Packaging:

10mg/Vial, 10 Vials/Kit; 1g/Bottle

Sample Available:

Yes

Price valid (until):

2026-02-04

Company Type:
Trader
Location:
China
Payment Terms:
100% TT in advance
Average Lead Time:
7 days
Qualification:
Main Products:

Chemical,Intermediate,5-amino-1mq,SLU-PP332,Tirzepatide,Peptide

  • Product Details

  • Seller Information

  • Inquiry History

  • Description
    Shop Spot supply 10mg vial Tirzepatide powder CAS 2023788-19-2 Tirzepatise-Detailed Image 1

    You can ask us for quotation and product information via Email, Phone, WhatsApp and other channels.

    Email: christy@horlden.com
    WhatsApp: +86 13572531251

    !!!  Welcome to consult  !!!

    Shop Spot supply 10mg vial Tirzepatide powder CAS 2023788-19-2 Tirzepatise-Detailed Image 2

    Product Name Cagrilintide
    CAS No. 1415456-99-3
    Molecular Formula C194H312N54O59S2
    Purity >99%
    Appearance White Powder
    Grade Pharmacy Grade
    Packaging 10mg/vial, 10vials/box 
    MOQ 10vials

    Cagrilintide   is an amylin-analog, now being developed in combination with the GLP-1 agonist semaglutide to achieve sustained weight loss in persons with overweight and obesity. Amylin, released with insu from beta cells in the pancreas, induces its satiating effect via both the homoeostatic and hedonic regions of the brain. Semaglutide, a GLP-1 receptor agonist, reduces appetite via GLP-1 receptors in the hypothalamus and increases the production of insu, and reduces glucagon secretion, delaying gastric emptying. These separate, but related mechanisms of action of an amylin-analog and a GLP-1 receptor agonist appear to have an additive effect on appetite reduction. Given the heterogeneity and complex pathogenesis of obesity, combination therapy with multiple pathophysiological targets is a logical approach to increasing weight loss response with pharmacotherapy. Cagrilintide alone, as well as cagrilintide in combination with semaglutide have shown promising weight loss in clinical trials that supports the further development of this therapy for sustained weight management.



    Shop Factory Supply Weight Loss Peptides Cagrilintide Lyophilized 5mg 10mg 15mg Vials CAS 1415456-99-3-Detailed Image 3

    Shop Spot supply 10mg vial Tirzepatide powder CAS 2023788-19-2 Tirzepatise-Detailed Image 4

    1.What's your payment terms?

    Standard terms: T/T in advance. Also L/C at sight is acceptable for large amount.

    2.What's your shipping time?

    We have bulk in stock, which means we can ship it to you immediately.

    3.How do you ensure the quality of your products?

    Strict QC with 6 steps testing from raw material purchase to finished product.

    4.How do you ship the order normally?

    For large qty order,ship the goods by sea. For small qty order, by air or express. We supply optional express for you, including DHL, FEDEX,UPS,TXT,EMS,and so on.

    5.What's your loading port?

    Usually Beijing, Shanghai, Qingdao, Tianjin, Guangzhou

    ECHEMI Editorial Reference

    Cagrilintide is a long-acting amylin analog and peptide-based pharmaceutical ingredient. As a pharmaceutical raw material, Cagrilintide is characterized by its peptide structure and amylin receptor activity. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.

    Certificates
    • Factory Supply Weight Loss Peptides Cagrilintide Lyophilized 5mg 10mg 15mg Vials CAS 1415456-99-3 Certificates 1 TDS

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    ‌Cagrilitide、Cagrilintide acetate、Caglitide、Kagliptin、Cargliptin、Cargilinitide

    CAS No.:

    1415456-99-3

    Molecular Formula:

    C194H312N54O59S2

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Chemical,Intermediate,5-amino-1mq,SLU-PP332,Tirzepatide,Peptide

    Location:

    9th Floor, Room 923, Building 3, Shiyuan Daguan, Xingtai 1st Street, Chanba Ecological District, Xi'an City, Shaanxi Province

    Payment Terms:

    100% TT in advance

    Average lead Time:

    7 days

    Total Annual Revenue:

    $2.5 million-$5 million

    Total Employees:

    11-50

    Year of Establishment:

    2015

    Xi'an Horlden Bio-Tech Co., Ltd is committed to promoting health application products such as chemical daily necessities, APIs, pharmaceutical intermediates and Cosmetic raw materials.

    We have established friendly business relationships with hundreds of customers from over 50 countries and regions. Our team is committed to providing customers with the highest quality products at reasonable prices and satisfactory service. For many years, our company has won the trust and favor of our customers with high-quality products, first-class services, and competitive prices.

    We will create the highest quality and most stable supply channel for customers, adhering to the spirit of serving customers, relying on strong funds and good cooperation reputation in the industry, to provide customers with higher quality products and services. At the same time, we are willing to strengthen exchanges and sincere cooperation with domestic and foreign merchants to create a better future together. It is your best supplier.

    Welcome to Xi'an Horlden Bio-Tech Co., Ltd!

  • Inquiry History
    66 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Cagrilintide

    20 MG Sep 30, 2026
    United States

    Cagrilintide

    10 MG Sep 23, 2026
    United States

    cagrilintide

    25 KG Sep 23, 2026
    Germany

    CAGRILINTIDE

    50 MG Sep 21, 2026
    United States

    Cagrilintide

    25 MG Aug 31, 2026
    Australia

    Cagrilintide

    1 G Aug 25, 2026
    Australia

    Cagrilintide

    20 MG Aug 17, 2026
    United States

    Retatrutid3

    10 MT Aug 4, 2026
    United States

    Cagrlintide

    1 MT Jul 31, 2026
    United Kingdom

    Cagrilintide

    10 MG Jul 31, 2026
    United States

    Retatrutide

    20 MT Jul 25, 2026
    United Kingdom

    cagrilintrude

    20 MG Jul 21, 2026
    United States

    Cagrilintide

    1 KG Jul 17, 2026
    United States

    Cagrilintide

    10 MG Jul 13, 2026
    Peru

    Cagrilintide 20MG vial

    10 PCS Jul 10, 2026
    United States

    Cagrilintide

    30 MG May 26, 2026
    France

    Cagrilintide

    10 MG May 22, 2026
    New Zealand

    Cagrilintide

    10 MG May 19, 2026
    United States

    Cagrilintide

    1 G May 18, 2026
    United States

    Cagrilintide

    20 MG May 8, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.